Huaren Pharmaceutical Co Ltd
300110
Company Profile
Business description
Huaren Pharmaceutical Co Ltd is a China-based company engaged in the manufacture, and sale of non-polyvinyl chloride and Non-PVC large capacity preparations. Its categories of products include conventional infusion, therapy infusion, and nutrition infusion. The company distributes its products in domestic market, with Northeast China as its main market.
Contact
No. 187 Zhuzhou Road
QingdaoShandong266100
CHNT: +86 53288701000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
2,491
Stocks News & Analysis
stocks
Meta earnings: Strong end to 2025 as AI monetization begins to show
Investors please with latest results.
stocks
Why doesn’t the market like the earnings from this US tech giant?
Good quarter with AI demand ramping.
stocks
Our Tesla fair value increases meaningfully
Progress on Robotaxi and Optimus shows real world AI growth.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,254.40 | 11.10 | 0.12% |
| CAC 40 | 8,071.36 | 4.68 | 0.06% |
| DAX 40 | 24,309.46 | 513.33 | -2.07% |
| Dow JONES (US) | 48,972.05 | 43.55 | -0.09% |
| FTSE 100 | 10,171.76 | 17.33 | 0.17% |
| HKSE | 27,968.09 | 141.18 | 0.51% |
| NASDAQ | 23,530.76 | 326.69 | -1.37% |
| Nikkei 225 | 53,585.53 | 226.82 | 0.43% |
| NZX 50 Index | 13,363.33 | 49.54 | -0.37% |
| S&P 500 | 6,939.31 | 38.72 | -0.55% |
| S&P/ASX 200 | 8,950.40 | 27.20 | 0.30% |
| SSE Composite Index | 4,157.87 | 0.11 | -0.00% |